Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1999Disease MarkersOpen Access

Mutation Analysis of the BRCA1 and BRCA2 Genes in the Belgian Patient Population and Identification of a Belgian Founder Mutation BRCA1 IVS5+3A>G

View Full Paper
Ask AI
Bookmark
Share

Authors

KCKathleen ClaesStatistics BelgiumEMEva MacháčkováMasaryk Memorial Cancer InstituteMVMichel De VosVrije Universiteit Brussel

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Claes et al. (1999) studied this question.

synapsesocial.com/papers/6ab472e128a6c74fc97bbeadhttps://doi.org/10.1155/1999/241046
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The genetic attributable risk of breast and ovarian cancer1996 · 750 citations
  2. 2A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families2020 · 170 citations